Pelvic inflammatory disease primary prevention

Pelvic inflammatory disease Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Pelvic Inflammatory Disease from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Pelvic inflammatory disease primary prevention On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Pelvic inflammatory disease primary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pelvic inflammatory disease primary prevention

CDC on Pelvic inflammatory disease primary prevention

Pelvic inflammatory disease primary prevention in the news

Blogs on Pelvic inflammatory disease primary prevention

to Hospitals Treating Pelvic inflammatory disease

Risk calculators and risk factors for Pelvic inflammatory disease primary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:  Seyedmahdi Pahlavani, M.D. [2]

## Overview[edit | edit source]

High-risk patients should be counseled on safer sex behaviors such as the use of condoms, and the risk of infection with STDs.

## Primary Prevention[edit | edit source]

* Risk reduction against sexually transmitted diseases through abstinence or barrier methods such as condoms.
* Regular gynecological (pelvic) exams with STD testing to screen for asymptomatic PID.[1]
* Evaluation and prompt treatment of sexual partners.

## References[edit | edit source]

1. ↑ Smith KJ, Cook RL, Roberts MS (2007). "Time from sexually transmitted infection acquisition to pelvic inflammatory disease development: influence on the cost-effectiveness of different screening intervals". Value Health. 10 (5): 358–66. doi:10.1111/j.1524-4733.2007.00189.x. PMID 17888100.CS1 maint: Multiple names: authors list (link)

Template:WH Template:WS